Both in Pharmaceuticals
Indaptus Therapeutics vs Tilray Brands
Over the past year INDP returned −1.0% and TLRY returned −80.7%; their daily moves had a correlation of 0.05.
INDP −1.0% TLRY −80.7%Growth of $1, one year, split-adjusted
| Metric | INDP | TLRY |
|---|---|---|
| Price | $3.09 | $2.53 |
| Market cap | $411.7M | $373.9M |
| Today | −7.49% | −4.17% |
| 1 month | +45.8% | −29.1% |
| 6 months | +44.4% | −58.9% |
| Year to date | +6.2% | −72.0% |
| 1 year | −7.5% | −81.4% |
| Revenue growth (YoY) | — | +22.7% |
| Gross margin | — | 30.1% |
| Net margin | — | −16.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.4× |
| Net cash | $11.6M | $16.6M |
| Dividend yield | — | — |
| Volatility (60d) | 191.8% | 47.1% |
| Short % of float | 7.4% | 14.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).